Chat with us, powered by LiveChat Week-2 Capstone | excelpaper.org/
+1(978)310-4246 credencewriters@gmail.com
  

Running head: THEORY LOGIC MODEL FOR DEPRESSION TREATMENT USING SERTRALINE AND COGNITIVE BEHAVIORAL THERAPYING IN TEENAGER

2

Running head: THEORY LOGIC MODEL FOR DEPRESSION TREATMENT USING SERTRALINE AND COGNITIVE BEHAVIORAL THERAPYING IN TEENAGER

Theory Logic Model for Depression Treatment Using Sertraline and Cognitive Behavioral Therapying in Teenager

Use of sertraline versus sertraline with CBT (cognitive behavioral therapy) to treat depression in teenagers age 12-1 8 over a 1-year period of time. – Approved by Dr. Silverman.

Context for the project/program

Depression is a major health concern for teenagers.

The United States Preventive Services Task Force (USPSTF) has recommended the ongoing screening procedure for depression in 12 to 18 years old within the primary care settings (Patra & Kumar, 2022).

First line therapy and only approved antidepressant is Sertraline (SSRI)(Moreland & Bonin, 2021). 

Effectiveness of treatment with only sertraline and conjunction with CBT.

Strategies proposed to address the need

Targets the early screening using different tools for teenagers’ depression as recommended by USPSTF for kids between 12-18(Mufson et al., 2022).

Choosing treatment using sertraline or CBT.

Using combination therapy with CBT and sertraline.

It helps meet the goals set by the United States Preventive Services Task Force (USPSTF), which proposes for early screening procedure (Mufson et al., 2022).

Need or Problem to be Addressed using the program

The treatment of depression among teenagers between age 13-19 using Sertraline and sertraline with CBT.

The teenagers’ signs and symptoms of depression. These symptoms tend to be considered the normal part of the growth (Loades et al., 2021).

How to get better outcome weather to use only sertraline or sertraline with CBT.

The Expected Outcomes

The expected outcome is an increase in the number of patients visiting the facility for early screening for depression. And receiving relief from depression using sertraline or sertraline with CBT.

The other expected outcome is a reduction in the rates of teenagers’ depression or symptoms.

Theoretical foundation for depression treatment using sertraline and CBT in teen age 12-18

Factors that will influence the use of strategy

The implementation of the treatment tool for depression to help in the early screening and symptom management process is influenced by several factors:

Such as the level of willingness and cooperation amongst healthcare providers, patients and parents.

Availability of mental health support for in and outpatient mental health need. (Mufson et al., 2022).

The partnership between the primary care practice and the mental health practitioners is also important in more in-depth CBT and treatment hence improving the clinical utility of this recourses.

Evidence-based for the proposed strategies

According to Moreland & Bonin, (2021) Roughly 40 percent of children and adolescents with depressive disorders are not treated in USA

 Psychotherapy alone is used most often

Second choice is monotherapy

List use treatment is psychotherapy plus an antidepressant.

The resulting impact of the project if the outcomes are achieved

The program’s effect is the institution of the universal program for depression in teenagers of ages 12to 18 years.

The program will ensure effective implementation and use of the available treatment tools, thus lowering the symptoms and progression of depression.

References

Loades, M. E., Read, R., Smith, L., Higson-Sweeney, N. T., Laffan, A., Stallard, P., … & Crawley, E. (2021). How common are depression and anxiety in adolescents with chronic fatigue syndrome (CFS) and how should we screen for these mental health co-morbidities? A clinical cohort study. European Child & Adolescent Psychiatry, 30(11), 1733-1743.  https://doi.org/10.1007/s00787-020-01646-w

Moreland, S., & Bonin, D. (2021). UpToDate. UpToDate – Evidence-based Clinical Decision Support | Wolters Kluwer. https://www.uptodate.com/contents/pediatric-unipolar-depression-and-pharmacotherapy-choosing-a-medication

Mufson, L., Morrison, C., Shea, E., Kluisza, L., Robbins, R., Chen, Y., & Mellins, C. A. (2022). Screening for depression with the PHQ-9 in young adults affected by HIV. Journal of Affective Disorders, 297, 276-282. https://doi.org/10.1016/j.jad.2021.10.037

Patra, K. P., & Kumar, R. (2021). Screening For Depression and Suicide in Children. In StatPearls [Internet]. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK576416/

error: Content is protected !!